Loading articles...
News Update:
June 2026 Issue Open Now |Quick Peer Review (7–10 Days) | DOI Available for Interested Authors | 20% Publication Fee Discount for First 10 Papers | Exclusive Group Submission Benefits | Academic & Conference Collaboration Opportunities | Research Visibility & Academic Promotion Support | Seminar, Institutional & Research Partnership Opportunities
WhatsApp
Back to Articles
Computer Science Open Access Peer Reviewed

PLANT-DERIVED ANTI-CANCER AGENTS IN CLINICAL USE


Authors

Ms. THARWAL POOJA NANDKISHOR, Dr. SUNIL KUMAR SHAH, Dr. SHAHAB AHMAD


Abstract

The expanded rate of cancer worldwide has prompted the revelation and advancement of novel remedial operators for the treatment of threat. Plant inferred bioactive mixes are viable wellspring of anticancer treatment and utilized as lead mixes for medication advancement. Plants have a long history of utilization in the treatment of malignancy. Plants have assumed an important job as a wellspring of compelling anticancer specialists and it is huge that over 60% of at present utilized enemy of malignancy operators are gotten from characteristic sources including plants, marine life forms and smaller scale life forms. This review discusses the effect of plant derived compounds on cancer prevention and their further effect on clinical use.


Keywords

Cancer; plants; clinical trial; compounds.

Publication Details

Published In

Volume 1, Issue 12